Rapid increase of SARS-CoV-2 seroprevalence during the second half of the COVID-19 pandemic year 2020 in the adult urban Albanian population.
Albania
COVID-19
Eastern Europe
IgG anti-Spike SARS-CoV-2 antibodies
SARS-CoV-2
Seroprevalence
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
05
08
2022
revised:
08
08
2023
accepted:
25
08
2023
medline:
8
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
This study aims to assess the changes in COVID-19 seroprevalence among the adult urban population of Albania between July and December 2020, when the Wuhan strain of SARS-CoV-2 virus was still prevalent in the country. Two independent, randomly selected samples of individuals aged 20-70 years residing in Metropolitan Tirana, Albania, were collected in June-July and December 2020. ELISA method was used for serological testing to determine IgG antibodies anti-S1-SARS-CoV-2.
Sections du résumé
Background
UNASSIGNED
This study aims to assess the changes in COVID-19 seroprevalence among the adult urban population of Albania between July and December 2020, when the Wuhan strain of SARS-CoV-2 virus was still prevalent in the country.
Methods
UNASSIGNED
Two independent, randomly selected samples of individuals aged 20-70 years residing in Metropolitan Tirana, Albania, were collected in June-July and December 2020. ELISA method was used for serological testing to determine IgG antibodies anti-S1-SARS-CoV-2.
Identifiants
pubmed: 37681122
doi: 10.1016/j.heliyon.2023.e19547
pii: S2405-8440(23)06755-5
pmc: PMC10481283
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e19547Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
BMJ Open. 2021 Apr 1;11(4):e045425
pubmed: 33795310
PLoS One. 2021 Dec 17;16(12):e0261330
pubmed: 34919576
Front Immunol. 2020 Apr 24;11:879
pubmed: 32391022
J Glob Health. 2022 Jul 25;12:03054
pubmed: 35871412
PLoS Med. 2022 Nov 10;19(11):e1004107
pubmed: 36355774
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
Euro Surveill. 2020 Aug;25(31):
pubmed: 32762796
PLoS One. 2021 Nov 2;16(11):e0250541
pubmed: 34727115
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
PLoS One. 2021 Jun 23;16(6):e0252617
pubmed: 34161316